MNR > Health & Pharma

Health & Pharma

December 5, 2013 - novo nordisk

Only 29% of people with diabetes report that their doctors ask them for input for their own treatment plans

December 3, 2013 - novo nordisk

Ryzodeg® offers improved glycaemic control with significantly lower rates of hypoglycaemia compared to biphasic insulin aspart 30 in adults with type 2 diabetes1

November 28, 2013 - Mehta Eye Clinic

Experience the Revolutionary New Completely Bladeless, Laser Assisted Cataract Surgery Technology – LENSX® – With Mehta Eye Clinic

November 21, 2013 - ContextVision

ContextVision Debuts US PLUSView Packages and New GOPView® Mammo2Features at RSNA 2013

October 31, 2013 - Cochlear

Cochlear Announces the Nucleus® 6 System in India – Simply Smarter in Every Hearing Situation

October 22, 2013 - Lex Clinical

LexClinical – A New Exceptional Offer in Negotiating Contracts for Clinical Trials

October 11, 2013 - HemoCue

HemoCue and the American Red Cross sign 5 year Product Supply Agreement for Hemoglobin Testing in North America

September 30, 2013 - Pierre Fabre

Une enquête* réalisée sur plus de 10 000 Français révèle que 38% des patients souffrant d’acné ne sont pas pris en charge par un professionnel de santé (ne se traitent pas ou se traitent seuls) et 17% des patients atteints d’acné sévère ne sont pas suivis

September 20, 2013 - INC International Nut & Dried Fruits

Scientifically Proven: Nuts Are Not Fattening

September 20, 2013 - Bayer HealthCare

Results from Phase III Pooled EINSTEIN Studies Reaffirm Bayer’s Xarelto® (rivaroxaban) as an Effective Single-Drug Solution for Venous Thromboembolism

September 2, 2013 - Klinikum Friedrichshafen & PaCentric®

PaCentric® Yields Improved Outcome for Trauma Patients

June 10, 2013 - Foamix

Superior Results in Foamix’s Minocycline Foam Clinical Study: 71% Reduction in Inflammatory Lesions in 6 weeks

April 19, 2013 - Astellas Pharma Europe Ltd.

New Expert Report Informs Europe’s Policymakers on Crucial Changes Needed to Improve the Diagnosis and Management of CDI

March 8, 2013 - ContextVision

ContextVision Pushes the Limits of Medical Imaging

February 26, 2013 - Hutchinson Healthcare

The Hutchinson Santé G-VIR® glove reduces the risk of HIV virus transmission in accidental needlesticks by 99%, according to a study published in the journal Surgery in February 2013

February 13, 2013 - Team Novo Nordisk

Team Novo Nordisk debuterer i italiensk cykelløb

February 13, 2013 - Team Novo Nordisk

Team Novo Nordisk, world’s first all-diabetes professional cycling team, competes in debut race

January 17, 2013 - SIRO

SIRO Clinpharm Unveils New Brand Identity

January 15, 2013 - Janssen

Economist Intelligence Unit Report Calls for Global Policy Innovation to Tackle the ‘Silent Pandemic’ that is Hepatitis C

January 9, 2013 - Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB and Abbott Sign Global Collaboration Agreement for Canine Oncology Therapies

December 4, 2012 - Novo Nordisk

Novo Nordisk to create the world’s first all-diabetes professional cycling team

November 28, 2012 - Almirall

Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

Novenber 20, 2012 - ContextVision

ContextVision Pushes the Limits of Medical Imaging

November 19, 2012 - LEO Pharma

Picato® gel receives EU marketing authorisation for treatment of actinic keratosis

November 13, 2012 - Bayer Healthcare - COMPASS

Landmark Phase III Study of Bayer’s Xarelto® (Rivaroxaban) Initiated for the Secondary Prevention of Myocardial Infarction and Death in Patients with Coronary or Peripheral Artery Disease

Show 5102550100 per page